Effect of Nilotinib in Cerebellar Ataxia Patients

NCT03932669 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Ataxia, Cerebellar
Ataxia, Progressive

Interventions

DRUG: Nilotinib

Sponsor

Seoul National University Hospital